Rafael Franco‐Cendejas

Author

Instituto Nacional de Rehabilitación ORCID

Also Known As

Franco-Cendejas Rafael, Mathias Bostrum, R Franco Cendejas, R. Franco-Cendejas, R. Franco‐Cendejas, Rafael Franco Cendejas, Rafael Franco-Cendejas, Rafael Franco Cendejas, Rafael Franco‐Cendejas

100

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Rehabilitación Universidad Nacional Autónoma de México Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Instituto Nacional de Cancerología Hospital General Dr. Manuel Gea Gonzalez

About

Rafael Franco‐Cendejas is an author at Instituto Nacional de Rehabilitación specializing in antimicrobial resistance, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	120
2	Health Sciences	3	3	107
3	Microbiology	3	3	107
4	Orthopaedics	2	2	24
5	Engineering	1	1	143

Rafael Franco‐Cendejas

Publications

876

Citations

H-Index

Page 1

	Year	Citations
Proceedings of the International Astronautical Congress, IAC Peter W. Taylor, Helena Bonet Rosado, David Negus, EngineeringAerospace EngineeringSpacecraft ControlSpace PolicySpace Architecture	2016	143
Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections Martha Yumiko Cruz-Muñiz, Luis Esaú López-Jácome, Melissa Hernández-Durán, International Journal of Antimicrobial Agents Antimicrobial SusceptibilityHealth SciencesMedicineAntibiotic AdjuvantAntibacterial Agent	2016	83
ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men Laura E. Martínez-Gómez, Brígida Herrera-López, Carlos Martínez-Armenta, Frontiers in Immunology	2022	70
A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period Elvira Garza‐González, Rayo Morfín‐Otero, Soraya Mendoza-Olazarán, PLoS ONE	2019	67
Increment Antimicrobial Resistance During the COVID-19 Pandemic: Results from the Invifar Network Luis Esaú López-Jácome, Diana Fernández-Rodríguez, Rafael Franco‐Cendejas, Microbial Drug Resistance	2022	56
Biologically synthesized silver nanoparticles as potent antibacterial effective against multidrug-resistant Pseudomonas aeruginosa C. Campo‐Beleño, Raquel A. Villamizar, Luis Esaú López-Jácome, Letters in Applied Microbiology	2022	47
Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network Elvira Garza‐González, Paola Bocanegra‐Ibarias, Miriam Bobadilla-del-Valle, PLoS ONE	2021	46
Origin of OXA-23 Variant OXA-239 from a Recently Emerged Lineage of Acinetobacter baumannii International Clone V Lucía Graña-Miraglia, Benjamin A. Evans, Luis Esaú López-Jácome, mSphere	2020	43
AiiM Lactonase Strongly Reduces Quorum Sensing Controlled Virulence Factors in Clinical Strains of Pseudomonas aeruginosa Isolated From Burned Patients Luis Esaú López-Jácome, Georgina Garza‐Ramos, Melissa Hernández-Durán, Frontiers in Microbiology	2019	39
The Evolution of Antimicrobial Resistance in Mexico During the Last Decade: Results from the INVIFAR Group Elvira Garza‐González, Rafael Franco‐Cendejas, Rayo Morfín‐Otero, Microbial Drug Resistance	2020	35

Page 1